Web-administered STAIR for Patients on Behavioral Health Waitlists

Last updated: November 25, 2025
Sponsor: Boston Medical Center
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Post-traumatic Stress Disorders

Treatment

CHW coaching

webSTAIR

Clinical Study ID

NCT06431022
H-44467
  • Ages > 18
  • All Genders

Study Summary

Posttraumatic stress disorder (PTSD) is a significant public health challenge with population prevalence rates in the US between 6.1 to 9.2%. There are large racial and socioeconomic inequities in access to PTSD treatment, as up to half (30-50%) of patients in safety net clinical settings meet criteria for PTSD, yet only 13% receive any behavioral health treatment. Workforce shortages are one major barrier to accessing care. Additional barriers to care can include heightened mental health stigma and mistrust of health services.

Digital mental health interventions (DMHIs) may be suitable within the continuum of care for PTSD in hospital settings, given their potential for rapid-access, scalability, and the high acceptability of DMHI among individuals with high stigma and social needs. Among the available DMHIs for PTSD, the investigators have selected web-administered Skills Training in Affective and Interpersonal Regulation (webSTAIR), based on emerging scientific evidence and a close collaboration with Boston Medical Center (BMC) users (patients and providers) in a previous pilot study in primary care.

The aim of this randomized study is to implement webSTAIR at BMC in the Recovery from Stress and Trauma through Outpatient Care, Research, and Education (RESTORE) Center's subspecialty clinic.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Client on the RESTORE Center waitlist at Boston Medical Center

  • Over 18 years of age

  • Able to receive therapy in English or Spanish (per participant report)

  • Exposure to trauma (as indicated by the Life Events Checklist for the DSM-5 [LEC-5])

  • Probable PTSD (as indicated by the PTSD Checklist for the DSM-5 [PCL-5] based on PCLscore of 33+).

  • Reasonable to access to technology (e.g., phone, computer, internet access).

Exclusion

Exclusion Criteria:

  • Patient declines to be in the study.

Study Design

Total Participants: 70
Treatment Group(s): 2
Primary Treatment: CHW coaching
Phase:
Study Start date:
November 15, 2024
Estimated Completion Date:
May 31, 2026

Connect with a study center

  • Boston Medical Center

    Boston, Massachusetts 02118
    United States

    Site Not Available

  • Boston Medical Center

    Boston 4930956, Massachusetts 6254926 02118
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.